Oregon Health & Science University has received more than $9 million in National Institutes of Health funding to develop advanced microphysiologic models — also known as organs‑on-a-chip — that recreate how cancers grow, spread and respond to treatment within bone and bone‑associated tissues.

The Marlene and Stewart Greenebaum Family Foundation has donated $5.5 million to the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) to help advance groundbreaking scientific research and compassionate, state-of-the-art cancer care in Maryland and across the region. The National Cancer Institute (NCI)-designated comprehensive cancer center is named in honor of Marlene and Stewart Greenebaum, who gave a transformative gift 30 years ago, after Mrs. Greenebaum’s successful treatment for breast cancer.

Experts found that technological advancements could reduce U.S. mortality from heat by 18% to 25% in the year 2100.

SAN DIEGO, APRIL 13, 2026 ― Jennifer Wargo, M.D., professor of Surgical Oncology and Genomic Medicine at The University of Texas MD Anderson Cancer Center, has been elected to the 2026 class of Fellows of the American Association for Cancer Research (AACR) Academy in recognition of her pioneering work to define interactions between the microbiome, cancer biology and treatment response. 

Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators discovered a new rare genetic disease that interferes with brain development.

The researchers published findings in Human Genetics and Genomics Advances that identify the faulty mutated gene. By exploring the biochemical consequences of the mutation, the investigators also showed that this typo in the genetic code interferes with normal cellular function.

Advanced liver disease (ALD) occurs when significant scarring causes the liver to lose function. Patients with ALD often have serious health challenges but have limited access to palliative care that could improve their quality of life. A new multicenter trial led by Manisha Verma, MD, and Victor Navarro, MD, at Jefferson Einstein Philadelphia Hospital demonstrates a new approach that could potentially transform access to palliative care for patients with ALD and address a major care gap.